Neurodegenerative conditions such as Parkinson’s disease are a major public health issue, especially given the aging population in Europe and beyond. Parkinson’s now affects more than 1 900 people per 100 000 among those aged 80 and older.
While a permanent cure for Parkinson’s and similar neurological diseases is not yet in sight, cell-replacement therapies (CTs) are considered very promising, particularly with the advent of specialized stem-cell technologies. Human stem cells come from a variety of sources and have the potential to become different cell types, including healthy nerve cells.
